Pfizer Limited (NSE:PFIZER)
5,000.50
-1.50 (-0.03%)
Nov 21, 2025, 3:29 PM IST
Pfizer Revenue
Pfizer had revenue of 6.42B INR in the quarter ending September 30, 2025, with 9.13% growth. This brings the company's revenue in the last twelve months to 23.75B, up 6.13% year-over-year. In the fiscal year ending March 31, 2025, Pfizer had annual revenue of 22.81B with 4.02% growth.
Revenue (ttm)
23.75B
Revenue Growth
+6.13%
P/S Ratio
9.63
Revenue / Employee
14.86M
Employees
1,598
Market Cap
228.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 22.81B | 881.80M | 4.02% |
| Mar 31, 2024 | 21.93B | -2.32B | -9.55% |
| Mar 31, 2023 | 24.25B | -1.86B | -7.13% |
| Mar 31, 2022 | 26.11B | 3.71B | 16.54% |
| Mar 31, 2021 | 22.40B | 887.20M | 4.12% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Biocon | 164.76B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |
Pfizer News
- 9 days ago - Pfizer shares jump over 5% as Q2 profit rises 19% YoY on strong operational performance - Business Upturn
- 3 months ago - Pfizer shares jump over 5% as Q1 net profit surges 27.2% YoY - Business Upturn
- 3 months ago - Pfizer shares jump over 2% after launch of next-gen 20-valent pneumococcal vaccine in India - Business Upturn